Archive · 28 Jun 2025
US Officials, Walmart Discussing Direct-to-Patient Drug Sales
The US government is talking with companies like Walmart about a new way for people to buy medicine.
Right now, medicine goes through a long process with many steps, making it expensive.
The government wants to help people get their medicine directly from the companies that make it, possibly at a lower cost.
They hope this will make medicine cheaper for Americans, which is one of the president's important goals.
The Department of Health and Human Services is leading these talks, but it's not yet clear how this will work or when it might happen.
US health officials met with Walmart and other retailers to explore direct-to-patient drug sales.
The meetings aimed to streamline how Americans get their medicines.
Discussions were led by the US Department of Health and Human Services.
Reducing high drug prices is a key health policy goal of President Trump.
One factor driving up drug costs is the multi-step process before drugs reach patients.
- Who
- US health officials, Walmart, and potentially other retailers.
- What
- US health officials discussed direct-to-patient drug sales with retailers.
- When
- The meetings occurred this week.
- Where
- United States
- Why
- To explore ways to streamline drug sales and potentially lower drug prices.
Current Drug Pricing System
Potential Alternative
Drug Pricing and Negotiation
Current Drug Pricing System
Pharmaceutical companies negotiate with Pharmacy Benefit Managers (PBMs).
Potential Alternative
President Trump seeks to lower drug costs to be equivalent to those of other countries.
- Key Players
- US Department of Health and Human Services, Walmart
- Focus
- Direct-to-patient drug sales
- Policy Goal
- Reduce drug prices
- Walmart's Involvement
- Offers prescription delivery